Company Filing History:
Years Active: 2013
Title: Eric Vicaut: Innovator in Angiogenesis Modulation
Introduction
Eric Vicaut is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the modulation of angiogenesis. His innovative work has the potential to impact therapeutic approaches for various medical conditions.
Latest Patents
Eric Vicaut holds a patent titled "Methods for modulating angiogenesis via dystrophin Dp71." This invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention highlights the role of Dp71 in angiogenesis and provides novel therapeutic approaches. It also introduces methods for screening agents that modulate angiogenesis, specifically targeting this protein. More specifically, the invention discusses the use of Dp71 or its variants for stimulating angiogenesis in subjects, particularly humans. Additionally, it covers the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject. Eric Vicaut has 1 patent to his name.
Career Highlights
Eric Vicaut is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Eric collaborates with notable colleagues, including Romain Bernard and Bénédicte Dupas. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Eric Vicaut is a key figure in the field of angiogenesis research, with a focus on innovative methods that could lead to significant medical advancements. His contributions are paving the way for new therapeutic strategies in the treatment of various conditions.